Literature DB >> 10404060

High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.

R Fukuzawa1, A Umezawa, K Ochi, F Urano, H Ikeda, J Hata.   

Abstract

Embryonal tumors such as Wilms' tumor (WT), embryonal rhabdomyosarcoma (eRMS) and hepatoblastoma have been thought to have a common pathogenetic mechanism. H19 was found to be inactivated in WT and eRMS either by loss of heterozygosity or by hypermethylation of the maternal allele. We show here that the expression of the H19 gene is inactivated by maternal allelic loss or hypermethylation in 7 out of 8 "sporadic" hepatoblastomas. Furthermore, we analyzed expression of the IGF2 gene. Loss of imprinting of the IGF2 gene was detected and linked to inactivation of the H19 gene in 2 hepatoblastomas. However, 2 sporadic cases demonstrated monoallelic expression of the IGF2 gene with inactivation of the H19 gene. Our results suggest that H19 may play a role as a common imprinted tumor suppressor gene in "sporadic" hepatoblastomas but may at times work independently of IGF2 expression. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404060     DOI: 10.1002/(sici)1097-0215(19990812)82:4<490::aid-ijc4>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.

Authors:  Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

2.  Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program.

Authors:  E Anders Kolb; Richard Gorlick; Richard Lock; Hernan Carol; Christopher L Morton; Stephen T Keir; C Patrick Reynolds; Min H Kang; John M Maris; Catherine Billups; Malcolm A Smith; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2010-12-22       Impact factor: 3.167

3.  The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.

Authors:  Raushan T Kurmasheva; Lorina Dudkin; Catherine Billups; Larisa V Debelenko; Christopher L Morton; Peter J Houghton
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

Review 4.  DNA methylation signatures for breast cancer classification and prognosis.

Authors:  Moshe Szyf
Journal:  Genome Med       Date:  2012-03-30       Impact factor: 11.117

5.  Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.

Authors:  Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Ding Xin; Yan Liu; Duo-Jiao Yu; Kai Su; Lin Zhu; Ying-Yuan Guo; Ke Wang
Journal:  Int J Med Sci       Date:  2016-11-09       Impact factor: 3.738

Review 6.  Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

Review 7.  Non-Coding RNAs in Pediatric Solid Tumors.

Authors:  Christopher M Smith; Daniel Catchpoole; Gyorgy Hutvagner
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

Review 8.  Hepatoblastoma in molecularly defined, congenital diseases.

Authors:  Gunther Nussbaumer; Martin Benesch
Journal:  Am J Med Genet A       Date:  2022-04-28       Impact factor: 2.578

9.  Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.

Authors:  S Honda; Y Arai; M Haruta; F Sasaki; M Ohira; H Yamaoka; H Horie; A Nakagawara; E Hiyama; S Todo; Y Kaneko
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

10.  Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells.

Authors:  P Bermejo-Álvarez; P Ramos-Ibeas; K E Park; A P Powell; L Vansandt; Bickhart Derek; M A Ramirez; A Gutiérrez-Adán; B P Telugu
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.